Pharmaceuticals Market Reports

Kalorama Information is your trusted source for market research on the pharmaceutical industry. Reports provide key trends, projections, and in-depth analysis for the markets you compete in. Our analysts work closely with pharmaceutical industry leaders to provide accurate market assessments while personally researching the market to offer keen insights into consumer and institutional trends.

<< back 1 2 3 4 5 6 7 8 9 10 next >>

Title	Published	Price
Emerging Cancer Vaccines: Market Forecasts, New Developments and Pipeline Analysis, 3rd Edition It is the general consensus of scientists that cancer vaccines will become a reality. Overall the cancer treatment market continues to grow and this demand sets the stage for vaccine products. Several promising vaccines: the propholactic Gardasil has created a pathway for new vaccine products. M-Vax, Ocon-Vax in  |  more... Search inside this report	Nov 1, 2008	$3,995.00
Glucose Testing Markets This report takes a bold look into the world glucose testing, ten years from now. It is not an exercise in crystal ball gazing. Rather, in this report, Kalorama offers a calculated look into the future, based on events taking place in the present. The report offers a quantitative  |  more... Search inside this report	Nov 1, 2008	$1,995.00
Effective Competitive Intelligence: A "How-To" Guide for Life Science Companies Often what separates successful marketing from bad is good competitive intelligence. This is true in life sciences as much as other industries. Many companies approach CI in a way that is unplanned, indirect and harmful to their business. But how does one know if they are conducting  |  more... Search inside this report	Nov 1, 2008	$499.00
Pharmaceutical Markets in the Middle East (Opportunities, Key Players, Trends in Egypt, Jordan, Israel, Saudi Arabia and UAE) At present the Middle East region constitutes as small percent of global pharmaceutical sales. However, ever-increasing populations and governmental healthcare reforms are likely to increase demand. These markets will be essential for pharmaceuticals companies exploring new opportunities for growth. Developing regions will be an integral part of expansion for  |  more... Search inside this report	Nov 1, 2008	$3,300.00
Smoking Cessation: World Markets Smoking cessation is among the most dynamic pharmaceutical markets, and one that is expected to grow despite economic conditions. More than 5 million deaths are attributed to nicotine each year. This has encouraged public health entities to pursue smoking cessation, and has driven development of smoking cessation products,  |  more... Search inside this report	Nov 1, 2008	$3,500.00
Outsourcing in Drug Development: The Contract CRO Market, 3rd Edition Driven by mounting market pressures, companies are increasingly implementing outsourcing strategies to increase revenues through faster drug development. By decreasing their in-house facilities and staff, and outsourcing more of their R&D functions, pharmaceutical and biotechnology companies are reshaping the drug development services industry. Kalorama Information's Outsourcing in Drug Development is  |  more...	Oct 1, 2008	$3,500.00
HIV: Markets for Diagnostics and Therapeutics The strategic concept of HIV/AIDS diagnosis and therapy is one of the most complex that the healthcare industry has ever seen. In order to cope with the challenges and opportunities of HIV/AIDS diagnostics and therapeutics, companies must think on a global basis. In addition to the basic pathology  |  more...	Oct 1, 2008	$3,500.00
Key Healthcare Opportunities for Technology Companies (Wireless in Healthcare 2008-12, High-Tech Patient Monitoring Systems, RFID in Pharma Manufacturing, US EMR Markets, RFID in Healthcare, Electronic Components for Medical Device Markets) According to Kalorama's experts, there is over a 40 billion dollar market for technology companies who can assist the healthcare industry meet its key challenges. This Kalorama Information Market Research Bundle, a combination of 7 Kalorama Information Market research reports - over 1200 pages of material. , presents those opportunities,  |  more... Buy by the section	Oct 1, 2008	$7,995.00
Lab Automation Markets Worldwide (Next-Generation Systems, Key Companies, Forecasts and Trends) The benefits of automation in the clinical laboratory are well documented. They involve replacing manual, potentially dangerous, error-prone steps with automated processes requiring minimal operator intervention. This approach can increase productivity, decrease turnaround time, improve staff safety, minimize errors, improve the handling of specimens, and allow labs to reallocate personnel  |  more...	Aug 1, 2008	$3,500.00
World Market for Respiratory Equipment and Disposables, 3rd. Edition The market for respiratory disposables and reusable accessories is witnessing dynamic changes. The market factors influencing demand in the U.S. are also present in Europe and the Asia/Pacific region — the aging of the population, technological trends and society’s acceptance of people with disabilities. Kalorama's World Market for  |  more...	Aug 1, 2008	$2,995.00
Facial Rejuvenation Markets Worldwide The aging of the population, namely the baby boomer demographic segment is driving the market for facial rejuvenation products. The size and wealth of this aging segment and its overwhelming desire to retain a youthful appearance are driving growth for aesthetic procedures. Worldwide, billions of dollars are spent annually  |  more... Search inside this report	Aug 1, 2008	$3,500.00
Diagnostic Test Service Commercialization in Multiplex and Esoteric Testing: A Roadmap to Diagnostics in the 21st Century Test services, once the norm in the diagnostics industry, then abandoned for reagent sales, are now making a comeback. IVD companies have established cGMP and CLIA-registered labs by which they offer their proprietary tests to physicians, hospitals and reference labs. These tests are outside the  |  more... Search inside this report	Aug 1, 2008	$3,500.00
The World Alzheimer's Disease Market (Incidence, Treatments, Key Companies, Pipeline and Trends) Alzheimer’s Disease is the most common cause of dementia, constituting 60% to 70% of all cases, and the risk with the disease doubles every 5 years after age 65. Incidence of the disease is increasing, and the resulting attention given to Alzheimer's Disease has encouraged development of new treatments.  |  more...	Aug 1, 2008	$2,995.00
Pharmaceutical Markets in Brazil, Russia, India and China ( BRIC nations ) Pharmaceutical markets in Brazil, Russia, India and China rank among the top twenty markets in the world with the potential to move up in ranking rather quickly. (China’s pharmaceutical market, for instance, is expected to show double-digit growth over the next five years.) Developing regions and petro-rich  |  more... Search inside this report	Jul 1, 2008	$3,500.00
Companion Diagnostics Markets (A Realistic Assessment of the Opportunities, Challenges, Key Players and Important Trends in 'Theranostics' and Personalized Medicine) This Kalorama Information report, Companion Diagnostics Markets (A Realistic Assessment of the Opportunities, Challenges, Key Players and Important Trends in Personalized Medicine) is truly a real-world guide to the potential market for companion diagnostics. Essentially the co-development of testing products to enhance the value and efficacy of a  |  more... Search inside this report	Jun 1, 2008	$2,995.00
Outsourcing in Drug Discovery: The Contract Research (CRO) Market, 3rd Edition 2008 has seen no decrease in the opportunities available for outsourcing drug discovery, for a number of reasons. New technologies increase the number of targets and accelerate the identification of active compounds. There is increasing pressure to develop new lead compounds due to the near-term loss of patent  |  more...	May 1, 2008	$3,500.00
Major World Markets for Stents and The Economics of Drug-Eluting Technology Since the arrival of drug-eluting (called drug-eluding by some) technology a few years ago with the promise of reducing restenosis, questions abound surrounding the future of the stent market: After numerous clinical studies and mixed cost-effectiveness results, how is drug-eluding technology expected to peform in the future? What  |  more... Search inside this report	May 1, 2008	$2,800.00
Kalorama Annual Subscription For companies seriously competing in the healthcare market, having up to date market information and important trends is crucial. Kalorama Information publishes high quality market research on the important and profitable sectors of the healthcare market, including: pharmaceuticals, biotech and diagnostics. Now, all of Kalorama Information's upcoming reports  |  more...	May 1, 2008	$75,000.00
World OTC Pharmaceutical Markets: Self-Medication, Developing and Petro-Rich Economies, BTC and Other Growth Trends Over-the-counter (OTC) drugs are well situated to capitalize on worldwide economic conditions. Customers in the US and in the world under time constraints and tight budgets prefer OTC and are opting to self-medicate where possible. Developing and petro-rich nations are pushing world demand for pharmaceuticals. Pharmacists are  |  more... Search inside this report	May 1, 2008	$3,200.00
The Return of the Rx to OTC Switch: Market Analysis and Product Management Strategies Lagging FDA approvals led to a brief absence of Rx to OTC switches in the pharmaceutical marketplace, but 2006 and 2007 saw a number of switches, and Kalorama Information believes this product management tactic will continue to be aggressively utilized as companies seek ways to extend revenue life.  |  more...	Apr 1, 2008	$1,995.00
Vaccines 2008: World Market Analysis, Key Players, and Critical Trends in a Fast-Changing Industry Few areas of pharmaceuticals have seen the fast-moving developments in the marketplace that the vaccine market has in 2007 and 2008. Since Kalorama Information last updated Kalorama Information's The World Market for Vaccines in the first quarter of last year, new products and better than expected profits have transformed  |  more...	Apr 1, 2008	$4,100.00
World Market for Prescription Generic Drugs, 6th Edition Generics, so long the force that has shaken up the branded pharmaceutical industry, is now facing its own challenges as an industry. While growth indications are strong, there are challenges for generic companies. In the next two years, consolidation will most likely rise; the sector is expected to  |  more... Search inside this report	Apr 1, 2008	$3,995.00
Biogenerics: The World Market for Biosimilars In one sense, the opportunity for follow-on proteins is as good as ever. Some of the biggest-selling biologics developed during the first phase of the biotechnology revolution in the 1980s, including human growth hormone (hGH) and insulin, have lost patent protection or are set to lose patent protection  |  more... Search inside this report	Apr 1, 2008	$3,500.00
Key Topics in Pharmaceutical Market Strategy 2008 (Drug Pricing, Rx to OTC switches, Retail Clinics, Prescribing Pharmacists, The Growing Out of Pocket Healthcare Market) Pharmaceutical marketers will face a challenging time in 2008 by all reports. Understanding the dynamics of the market can assist in better planning and strategy. This Kalorama Information Report Bundle combines 5 of the most important topics for those in the pharmaceutical industry in a strategic planning, business  |  more... Search inside this report	Mar 15, 2008	$6,995.00
The Worldwide Market for Cancer Diagnostics, 3rd Edition Who are the major players in testing for the number two killer in the world? What revenues can companies competing in this market expect in the next five years? How will the impact of trends such as an increased role of pharmacodiagnostics , the use of multiplex assays and  |  more...	Mar 1, 2008	$3,995.00
Title	Published	Price

<< back 1 2 3 4 5 6 7 8 9 10 next >>